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SUMMARY
The Wnt/b-catenin pathway and Nanog are key reg-
ulators of embryonic stem cell (ESC) pluripotency
and the reprogramming of somatic cells. Here, we
demonstrate that the repression of Dkk1 by Nanog,
which leads indirectly to b-catenin activation, is
essential for reprogramming after fusion of ESCs
overexpressing Nanog. In addition, b-catenin is
necessary in Nanog-dependent conversion of prein-
duced pluripotent stem cells (pre-iPSCs) into iPSCs.
The activation of b-catenin by Nanog causes fluctu-
ations of b-catenin in ESCs cultured in serum plus
leukemia inhibitory factor (serum+LIF) medium, in
which protein levels of key pluripotency factors
are heterogeneous. In 2i+LIF medium, which favors
propagation of ESCs in a ground state of pluripo-
tency with many pluripotency genes losing mosaic
expression, we show Nanog-independent b-catenin
fluctuations. Overall, we demonstrate Nanog and
b-catenin cooperation in establishing naive pluripo-
tency during the reprogramming process and their
correlated heterogeneity in ESCs primed toward
differentiation.
INTRODUCTION
The activation of the Wnt signaling pathway enhances embry-
onic stem cell (ESC) self-renewal and reprogramming of somatic
cells to pluripotency (Ku¨hl and Ku¨hl, 2013; Lluis et al., 2008; Mar-
son et al., 2008; Sato et al., 2004; Sokol, 2011). b-Catenin is the
key effector of this pathway, and its stability is modulated by the
destruction complex, which is formed by Gsk3, Axin, APC, and
CK1 (Stamos and Weis, 2013). Dickkopf-related protein 1
(Dkk1) is one of the b-catenin targets, and it binds the LRP-5/6
Wnt coreceptor to prevent the binding of its ligand (Kawano
and Kypta, 2003).
Mouse ESCs are transcriptionally heterogeneous. In serum
plus leukemia inhibitory factor (serum+LIF) medium, Esrrb (van
den Berg et al., 2008), Stella (Hayashi et al., 2008), Nanog,
zinc-finger protein 42, T box 3, and Klf4 showmetastable protein
expression levels (Cahan and Daley, 2013). In contrast, in ESCs
cultured in 2i+LIF medium, which include Mek and GSK3 inhib-
itors (Ying et al., 2008), the expression profile is homogeneous
(Marks et al., 2012; Wray et al., 2010).
Nanog is a key factor in the ESC core pluripotency network
and is necessary for maintenance of the naive pluripotent state
of ESCs (Chambers et al., 2003; Loh et al., 2006; Mitsui et al.,
2003). Overexpression of Nanog enhances cell-fusion-mediated
reprogramming (Silva et al., 2006) and is essential for conversion
of preinduced pluripotent stem cells (pre-iPSCs) to fully reprog-
rammed iPSCs (Silva et al., 2009).
Here, we demonstrate that Nanog controls b-catenin through
direct inhibition of Dkk1, which results in b-catenin accumulation
in ESCs overexpressing Nanog. b-Catenin is essential for re-
programming of somatic cells after their fusion with Nanog-over-
expressing ESCs and for the conversion of pre-iPSCs into
iPSCs, when Nanog establishes naive pluripotency during the
reprogramming process.
Furthermore, we show that b-catenin fluctuates synchro-
nously with Nanog in mouse ESCs cultured in serum+LIF, while
its fluctuations in 2i+LIF are independent of Nanog. We derived
a differential equation-based model that captures Nanog and
b-catenin fluctuations with bistable dynamics.
RESULTS
Nanog Regulates the Wnt/b-Catenin Pathway by
Repressing Dkk1
ESC pluripotency is regulated by a network of signaling path-
ways and transcription factors. We examined the functional cor-
relation between Nanog and b-catenin activities in ESCs.
First, we investigated Wnt pathway activity in ESCs that
overexpress Nanog (EF4 cells) (Silva et al., 2006) and in ESC
mutants lacking one Nanog allele (Nanog bgeo/+ cells) (Mitsui
et al., 2003). EF4 cells accumulated high levels of b-catenin,
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Figure 1. Nanog Stabilizes b-Catenin Levels by Inhibiting Dkk1
(A and B) Western blot of total b-catenin and Nanog in E14Tg2a, EF4 (A), RF8, and Nanog bgeo/+ cells (B).
(C and D) Quantitative PCR (qPCR) of Wnt pathway targets in E14Tg2a, EF4 (C), RF8, and Nanog bgeo/+ cells (D).
(E and F) FACS analysis of GFP distribution of TNGA and EL55 cells treated with Chiron (3 mM) for 1 day and the Mek inhibitor PD184352 (3 mM) for 7 days.
(G) Chromatin immunoprecipitation (ChIP) of Nanog on Dkk1 and Igx1A promoters in E14Tg2a and EF4 cells.
(legend continued on next page)
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while Nanog bgeo/+ cells showed reduced levels, as compared
to controls (E14Tg2a and RF8 cells, respectively) (Figures 1A,
1B, and S1A). The Wnt/b-catenin target genes Axin2, Cdx1,
and Brachyury were expressed at higher levels in EF4 cells (Fig-
ure 1C), and at lower levels in Nanog bgeo/+ cells (Figure 1D),
compared to controls. These data suggest that Nanog promotes
b-catenin accumulation in ESCs. Of note, levels of Nanog were
not altered in EF4 cells treated with the Wnt pathway inhibitors
Dkk1 or IWP2, while b-catenin levels and activity were reduced
(Figures S1B–S1D).
Wenext askedwhetherb-catenin isNanogdependent in TNGA
cells, an ESC line expressing GFP from Nanog allele (Chambers
et al., 2007), and in EL55 cells, an ESC line expressing endoge-
nous b-catenin fused with GFP (Figures S1E–S1I). GFP-tagged
b-catenin colocalized and had correlated expression levels with
endogenous b-catenin and did not show abnormal endosomal
accumulation (Figures S1J and S1K; r = 0.98). Untagged and
GFP-tagged forms of b-catenin in EL55 cells were increased
upon activation of the Wnt pathway using the GSK3 inhibitor
Chiron (CHIR99021) (Figure S1L), and b-catenin target genes
were turned on by Chiron treatment (Figure S1M).
To investigate whether b-catenin is Nanog dependent, we
used a Mek inhibitor (Meki) (Ying et al., 2008), which upregulates
Nanog (Silva et al., 2009), andChiron. UponChiron treatment, the
GFP distribution in TNGA cells was unaltered, while EL55 cells
became almost all GFP+ (Figures 1E and 1F, Hb-cat). In contrast,
upon Nanog induction using theMeki, both TNGA and EL55 cells
becameGFP+ (Figures 1E and 1F, Hb-cat, HN), which suggested
that Nanog controls b-catenin stabilization. Moreover there was
no b-catenin accumulation in Nanog null cells (Nanog bgeo/
Hygro) (Mitsui et al., 2003) upon Meki treatment (Figure S1N).
Dkk1 is a secreted factor (Niehrs, 2006) expressed by ESCs
(Kotini et al., 2011) that prevents binding of the Wnts (Kawano
and Kypta, 2003). Having observed activation of Wnt targets in
EF4 cells and induction of b-catenin accumulation by Nanog,
we investigated whether Nanog is a repressor of Dkk1. We
show Nanog binding to the Dkk1 promoter in ESCs and
increased binding in EF4 cells (Figure 1G), which suggests direct
regulation of Dkk1 transcription by Nanog. Accordingly, Dkk1
mRNA and protein levels were lower in EF4 cells and higher in
Nanog bgeo/+ cells compared to controls (Figures 1H and 1I).
Dkk1 levels were comparable in the different cell media (Fig-
ure 1J), indicating the prevalence of its autocrine regulation of
the Wnt pathway.
Overall, these data show that Nanog represses Dkk1 tran-
scription and thereby induces indirect activation of the Wnt/
b-catenin pathway by promoting b-catenin accumulation.
Nanog Enhances Cell-Fusion-Mediated Reprogramming
by Increasing b-Catenin Accumulation upon Dkk1
Repression
b-Catenin accumulation and Nanog overexpression in ESCs
enhance reprogramming after fusion (Lluis and Cosma, 2009;
Lluis et al., 2008, 2010; Silva et al., 2006). As Nanog overexpres-
sion stabilizes b-catenin in EF4 cells through Dkk1 repression,
we investigated whether reprogramming of somatic cells after
EF4-cell fusion was due to Nanog in cooperation with the Wnt/
b-catenin pathway. Thus, we fused NPCs-Oct4-Puro-GFP
(neural precursor cells carrying the Oct4-Puro-GFP transgene)
with wild-type ESCs, with EF4, and with Dkk1-treated EF4 cells
(Figures 2A and S1C). GFP-positive reprogrammed clones were
stained for alkaline phosphatase (AP) and counted. As expected,
overexpression of Nanog in EF4 cells increased reprogramming.
In contrast, AP+ and GFP+ colonies were strongly reduced by
Dkk1 pretreatment of EF4 cells (Figures 2B, 2C, and S2A). Of
note, cell-fusion efficiency was not modulated by Nanog overex-
pression or Dkk1 treatment (Figure S2B). These data indicated
that activation of the Wnt pathway is essential for enhancement
of reprogramming by Nanog.
These results were confirmed by the silencing of Dkk1 in
wild-type ESCs (E14Tg2a) with a small hairpin (ShRNA) (Figures
S2C–S2E), which induced stabilization of b-catenin (Figure S2D),
increased levels of Axin2, and no changes in Nanog expres-
sion (Figure S2E); AP+ and GFP+ colonies were increased in
ShRNA-Dkk1-E14Tg2a fused with NPCs-Oct4-Puro-GFP (Fig-
ures S2F–S2H).
Next, we generated DN4 and N1 clones after overexpressing
Nanog in ESCs deleted for b-catenin (D/D) and in the parental
wild-type cell line (fl/fl) (Lyashenko et al., 2011). These lines
carried Nanog expression levels comparable to those in EF4
cells (Figure S2I), while Axin2, Cdx1, andBrachyurywere overex-
pressed in N1, but not in DN4 cells (Figure S2J).
There was no increase in AP+ and GFP+ clones after fusion of
DN4 cells with NPCs-Oct4-Puro-GFP, while there was increased
reprogramming after fusion of N1 cells, with respect to controls
(Figures 2D, 2E, and S2K). These data show that b-catenin is
essential in the reprogramming process mediated by Nanog.
We ruled out reprogramming defects due to loss of stem fea-
tures or cell-fusion capability of b-catenin null cells. Indeed, in
serum+LIF medium, b-catenin null and the parental line had
similar morphology (Figure S2L) and expressed normal levels
of pluripotency genes (Figures S2M and S2N, fl/fl, D/D;
Lyashenko et al., 2011). Furthermore, b-catenin null cells had
no cell-adhesion defects, as shown by normal E-cadherin levels,
which was probably due to upregulation of Plakoglobin and
unchanged fusion efficiency (Figures S2N–S2P, fl/fl, D/D; Lya-
shenko et al., 2011). Similar features were also confirmed in
another b-catenin null ESC line (Wray et al., 2011) (Figures S2N
and S2O, fl/, D/; Wray et al., 2011).
Esrrb cooperates with Nanog in enhancement of reprogram-
ming (Festuccia et al., 2012; Martello et al., 2012). We observed
no changes in the expression of Esrrb, thereby excluding its role
in reprogramming when Wnt/b-catenin activity was perturbed
(Figure S2Q).
Finally, we also noted that Wnt3a levels were slightly higher in
EF4 cells as compared to DN4 cells (Figure S2R); however,
(H) Dkk1 qPCR in EF4, wild-type ESCs (E14Tg2a, RF8), and Nanog bgeo/+.
(I) Western blot of Dkk1 in wild-type and mutant ESCs.
(J) Secreted Dkk1 concentration measured by ELISA assay.
Data are means ± SEM (n = 3). p > 0.1, *p < 0.05, **p < 0.01.
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Figure 2. b-Catenin Is Essential for Nanog-Mediated Reprogramming of NPCs after Cell Fusion and for Conversion of Pre-iPSCs in iPSCs
(A) Scheme of spontaneous cell fusion between mESCs and NPCs.
(B and C) Reprogramming efficiency of E14Tg2a, EF4, and EF4 cells pretreated with Dkk1 (50 ng/ml, 24 hr), counting AP+ (B) and GFP+ (C) colonies. (C, inset)
Representative GFP clone.
(legend continued on next page)
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Chiron treatment induced upregulation of Wnt3a to similar levels
in wild-type and bgeo/+ ESCs over the controls (Figure S2S).
These data therefore excluded that overexpression of Nanog in-
duces an upregulation of Wnt3a, which is dependent on b-cate-
nin instead.
To further investigate b-catenin and Nanog interplay in reprog-
ramming, we asked whether ESCs deleted for Nanog in one
allele (Nanog bgeo/+) might not reprogram somatic cells after
fusion, due to low b-catenin accumulation. Thus, we treated
Nanog bgeo/+ and RF8 cells with Chiron, to stabilize b-catenin
and activate target genes, without altering the levels of Nanog
(Figures S2T and S2U), and fused these cells with NPCs-Oct4-
Puro-GFP. No reprogrammed clones were selected after fusion
of Nanog bgeo/+ ESCs, while reprogramming was greatly
increased after fusion of Nanog bgeo/+ ESCs pretreated with
Chiron (Figures 2F, 2G, and S2V). These data demonstrate that
b-catenin stabilization with Chiron can rescue the lack of reprog-
ramming after fusion of Nanog bgeo/+ ESCs.
Of note, Nanog bgeo/+ cells do not show pluripotency defects
(Mitsui et al., 2003). Furthermore, E-cadherin and Plakoglobin
levels and fusion efficiency were comparable to the parental
line (Figures S2W–S2Y). Finally, reprogramming efficiency was
not rescued by Wnt3a pretreatment of Nanog bgeo/+ ESCs
(Figures S2Z–S2BI). The low Nanog levels and consequently
high Dkk1 in this cell line (Figure 1I) likely impaired the binding
of Wnt3a to its receptor, as shown also by the lack of Wnt
pathway activity (Figure S2CI).
b-Catenin Is Essential for Nanog-Mediated Conversion
of Pre-iPSCs into iPSCs
Stepwise modulation of the Wnt pathway is necessary for re-
programming mouse embryonic fibroblasts (MEFs) into iPSCs
(Aulicino et al., 2014; Ho et al., 2013). Furthermore, Nanog is
necessary for pre-iPSCs to become iPSCs (Silva et al., 2009).
However, whether the Wnt pathway and Nanog cooperate in
this conversion has not been studied.
MEFs stably carrying a GFP reporter for Nanog were infected
with the mouse transcription factors Oct4, Klf4, Sox2, and
c-Myc (OKSM) (Figure 2H). In pre-iPSCs positive for SSEA-1
and negative for Nanog (Figure S2DI), we upregulated Nanog
using a Mek inhibitor (Silva et al., 2008), and at the same time,
we inhibited the Wnt pathway by adding Dkk1 (Figures 2H
and S2EI). There was a significantly reduced number of iPSCs
generated from pre-iPSCs, while iPSCs were efficiently gener-
ated without inhibition of the Wnt pathway (Figures 2I–2K and
S2FI–S2HI). We then further showed that inhibition of the Wnt
pathway impairs the activity of Nanog in the late phase of re-
programming, as although Nanog was overexpressed in pre-
iPSCs, the addition of Dkk1 drastically decreased iPSC number
(Figures S2II–S2KI).
Next, we investigated whether deletion of b-catenin in pre-
iPSCs impairs their conversion into iPSCs. MEFsb-cat fl/fl were
infected with OKSM (Figure 2L). The b-catenin gene was deleted
in pre-iPSC colonies positive for SSEA-1 and negative for Nanog
(FiguresS2LI andS2MI). The deletionwas not complete, however.
After induction of Nanog with Mek inhibitor, pre-iPSCsb-cat /
failed to become iPSCs, and there were no clones positive for
Nanog and negative for b-catenin (Figures 2M and S2NI). The
fewNanog-positive clonesselected (Figure2M)werealsopositive
for b-catenin, which indicated that they derived from MEFs that
escaped b-catenin deletion. These were indistinguishable from
iPSCs generated from pre-iPSCsb-cat fl/fl (Figures 2M and S2OI).
These data demonstrate that b-catenin is essential in the conver-
sion of pre-iPSCs into iPSCs in establishing Nanog-mediated
ground-state pluripotency.
b-Catenin Fluctuates Synchronously with Nanog in
Serum+LIF Medium
Nanog fluctuates in ESCs cultured in serum+LIFmedium (Cham-
bers et al., 2007; MacArthur et al., 2012). We therefore investi-
gated whether, apart from controlling reprogramming of somatic
cells, the above-described Nanog regulation of Dkk1 affects
b-catenin distribution and dynamics in ESCs.
In immunofluorescence experiments, there were heteroge-
neous levels of total and active b-catenin in E14Tg2a cultured
in serum+LIF, with active b-catenin localized also in the nucleus,
as expected (Figure 3A). Single cells expressing more Nanog
also expressed high total and active b-catenin (Figure 3A), with
high correlation (r = 0.78; Figure 3A). b-catenin-GFP was also
heterogeneously expressed in EL55 cells, with these expressing
high levels of b-catenin and Nanog, or low levels of both, as indi-
cated by the correlation plot (r = 0.76; Figure 3B). Overall, these
data indicate correlated heterogeneity of b-catenin and Nanog in
ESCs cultured in serum+LIF.
We next investigated the dynamics of b-catenin in population
studies and with time-lapse single-cell imaging. EL55 cultured in
serum+LIF showed 45% ± 10% of GFP-positive cells, 15% ±
10% of GFP-negative cells, and a population with intermediate
GFP levels (Figure 3C, Hb-cat, Lb-cat). Sorted Hb-cat (GFP+)
had higher levels of both b-catenin and Nanog with respect to
(D and E) Reprogramming efficiency comparing Nanog overexpression in b-catenin D/D background (DN4) and in b-catenin fl/fl background (N1), counting AP+
(D) and GFP+ (E) colonies. (E, inset) Representative GFP clone.
(F and G) Reprogramming efficiency stabilizing b-catenin with Chiron (3 mM, 24 hr) in bgeo/+ cells, counting AP+ (F) and GFP+ (G) colonies. (G, inset) Repre-
sentative GFP clone.
(H) Scheme of iPSC generation. MEFsNanog-GFP were infected with OKSM. Nanog-negative pre-iPSCs were cultured in ESC medium with the Mek inhibitor
PD0325901 (Meki, 1 mM) ± Dkk1 (50 ng/ml).
(I and J) Immunofluorescence of pre-iPSCs grown in ESCmedium containingMeki and Dkk1 (I) and of pre-iPSCs grown in ESCmedium plusMeki (without Dkk1),
converted into iPSCs (J).
(K) Percentage of Nanog-GFP+ iPSCs over total pre-iPSC clones.
(L) Scheme of iPSC generation fromMEFsb-cat flox/flox after infection with OKSM. b-catenin was deleted in Nanog-negative pre-iPSCs with tamoxifen (1 mM). Pre-
iPSCs ±tamoxifen were cultured in ESC medium with Meki to stabilize Nanog.
(M) Percentages of Nanog+ iPSCs over total pre-iPSC clones.
Data are means ± SEM (n = 5). p > 0.1, *p < 0.05, **p < 0.01, ***p < 0.0001. Scale bars represennt 200 mm (C, E, and G inset) and 25 mm (I and J).
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Figure 3. Correlated Fluctuations of b-Catenin and Nanog in ESCs Cultured in Serum+LIF Medium
(A and B) Immunofluorescences of total b-catenin, active b-catenin (ABC) and Nanog in E14Tg2a and EL55 cells cultured in serum+LIF. Arrows indicate zoomed
regions with correlated expression of b-catenin and Nanog. The correlation plots of endogenous (A) and GFP-tagged (B) b-catenin with Nanog are shown
(r, Pearson correlation coefficient).
(C) GFP distribution of the EL55 clone in serum+LIF analyzed by FACS. Hb-cat, high b-catenin; Lb-cat, low b-catenin.
(D) Western blot of GFP-positive (Hb-cat) and GFP-negative (Lb-cat) EL55 cells from FACS sorting (day 0) and 4 days of culture (day 4).
(legend continued on next page)
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sorted Lb-cat (GFP) cells (Figure 3D, day 0). Levels of pluripo-
tency genes were comparable (Figures S3A and S3B).
Next, we asked whether b-catenin spontaneously fluctuates
over time, as had already been reported for Nanog. Hb-cat
(GFP+) and Lb-cat (GFP–) fluorescence-activated cell sorting
(FACS)-sorted cells passed from both Nanog and b-catenin
‘‘high states’’ to ‘‘low states’’ and vice versa, after 4 days of cul-
ture (Figure 3D).
We then analyzed b-catenin fluctuations using time-lapse sin-
gle-cell imaging. The GFP signal was normalized against stably
expressed red fluorescent protein fused to histone H2B (H2B-
RFP). Unsynchronized EL55 cells cultured in serum+LIF showed
increases and decreases in GFP levels over time (Movie S1; Fig-
ures 3E and S3C).
Finally, we showed correlated dynamics of Nanog and b-cat-
enin in TNGA cells. FACS-sorted GFP+ (HN) had high levels of
b-catenin, while GFP (LN) cells had almost no b-catenin accu-
mulation (Figure 3F, day 0). GFP+ cells had decreased levels of
both b-catenin and Nanog at day 4. Symmetrical dynamics
were observed in the GFP population (Figure 3F). These data
indicate that the levels of b-catenin and Nanog are dynamically
interconnected in ESCs cultured in serum+LIF.
A Mathematical Model Recapitulates Nanog- and
b-Catenin-Correlated Fluctuations
Different models have been proposed to explain Nanog dy-
namics (Fidalgo et al., 2012; Glauche et al., 2010; Kalmar et al.,
2009; Navarro et al., 2012). To recapitulate the two different sub-
states of Nanog and b-catenin in serum+LIF, we modeled the
system as a bistable one, in which the low and high states of
Nanog, and consequently of b-catenin, are both stable and the
transition from one to the other is due to noise. Of note, gene
expression noise is a major determinant of the distribution of
Nanog in stem cells (Wu and Tzanakakis, 2012).
Oct4, Sox2, Nanog, Dkk1, and b-catenin interactions are
considered in our model. The topology encompasses a positive
autofeedback loop of Oct4-Sox2 heterodimer (Glauche et al.,
2010), which activates Nanog expression (Rodda et al., 2005),
and a positive autofeedback loop of Nanog (Loh et al., 2006;
Mullin et al., 2008) (Figures 3G and S3D). Nanog has also been
suggested to fluctuate because of autorepression (Fidalgo
et al., 2012; Navarro et al., 2012). Here, we described the system
using a minimal topology that encompasses bistability, as we
mainly focused on the effects of Nanog fluctuations on b-catenin
through Dkk1 repression, rather than on the regulation that
controls the dynamics of Nanog.
We used first-order degradation kinetics and Hill functions for
the transcriptional interactions. The model includes stochastic
terms, implemented as zero-mean Gaussian processes, which
are added to the equations for Nanog and b-catenin (Figure 3H).
Starting from parameter values reported before (Abranches
et al., 2013; Glauche et al., 2010), we measured the half-life of
b-catenin (Figures S3E and S3F; Table S1) andmodified the tran-
scription rates and the amplitude of noise to fit the distribution of
Nanog and b-catenin in TNGA and EL55 cells, respectively.
When simulating over time, a typical trajectory of Nanog,
Dkk1, and b-catenin is presented (Figure 3I); due to noise, in ser-
um+LIF, cells can switch from one steady state to the other, with
correlated Nanog and b-catenin dynamics in antiphase with the
Dkk1 ones. Simulating the model for a high number of cells and
estimating the Kelner density (Cao et al., 1994), we recapitulated
the stationary GFP distribution of TNGA and EL55 cells (Figures
1E, 1F, steady-state conditions, and Figure 3J). We captured the
distributions observed in the two cell lines and the distances be-
tween the positive and negative states. Figure 3K shows typical
bistability continuation plots; continuing the steady state on s4
(the maximal rate of the autofeedback of Nanog), two saddle-
node bifurcations delimit the bistability region.
b-Catenin Protein Is Heterogeneous in ESCs Cultured in
2i+LIF Medium
Recent reports have shown that Nanog and other members
of the pluripotency network do not fluctuate when ESCs are
cultured in 2i+LIF medium (Ying et al., 2008). We therefore
asked whether b-catenin heterogeneity is also abrogated in
ESCs cultured in 2i+LIF.
Nanog was overall homogeneously expressed in E14Tg2a
cells, and instead, b-catenin was heterogeneous, with some
cells accumulating more b-catenin in the nucleus and in the
membranes than other cells in the same clone (Figure 4A).
Furthermore, the correlation between Nanog and b-catenin
levels was much lower in ESCs cultured in 2i+LIF (r = 0.51), as
compared to serum+LIF (r = 0. 78) (Figures 3A and 4A). In
EL55 cells cultured in 2i+LIF, although b-catenin-GFP fully colo-
calized with endogenous b-catenin with correlated expression
(r = 0.98; Figure S4A), it was heterogeneously expressed, poorly
correlating with Nanog (r = 0.56; Figure 4B).
Single-cell time lapses of EL55 cells cultured in 2i+LIF showed
increases or decreases of GFP levels over time (Movies S2 and
S3; Figures 4C, S4B, and S4C), which clearly demonstrated
that b-catenin can fluctuate in ESCs in 2i+LIF.
In addition, we studied the dynamics of the pathway activity
using TOP-dGFP, a well-known Wnt reporter carrying destabi-
lized GFP (Biechele and Moon, 2008). Only 8% ± 5% of cells
were GFP+ in 2i+LIF medium (Figure 4D). Furthermore, after
plating the unsorted cells, we observed a variable number of
GFP+ cells over time (Figures 4E and S4D), which confirmed the
heterogeneous activity of theWnt/b-catenin pathway. In addition,
(E) Snapshots of live EL55 cell imaging. Quantifications of GFP signal normalized against RFP signal, plotted as a function of time. White arrows, GFP switch off;
yellow arrows, GFP switch on.
(F) HN (GFP+) and LN (GFP) cells FACS sorted from TNGA ESCs and analyzed by western blot. HN, high Nanog; LN, low Nanog.
(G) Topology of the interactions among the Oct4-Sox2 heterodimer, Nanog, Dkk1, and b-catenin.
(H) Differential equations (DEs) model of the network.
(I) Nanog, Dkk1, and b-catenin simulated time course.
(J) Bimodal distribution of Nanog and b-catenin.
(K) Bifurcation plots of the model; red and blue lines indicate stable, while gray lines indicate unstable steady state. Scale bar represents 25 mm.
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Figure 4. Dynamics of b-Catenin in Mouse ESCs Cultured in 2i+LIF Medium
(A and B) Immunofluorescences of b-catenin, active b-catenin (ABC), and Nanog in wild-type ESCs (E14Tg2a) and EL55 cells cultured in 2i+LIF. Arrows indicate
zoomed regions with both correlated and uncorrelated expression of b-catenin and Nanog. The correlation plots of endogenous (A) andGFP-tagged (B) b-catenin
with Nanog are shown (r, Pearson correlation coefficient).
(C) Snapshots of live EL55 cells imaged in 2i+LIF. Quantification of GFP normalized against RFP signal is plotted. White arrows, GFP switch off; yellow arrows,
GFP switch on.
(legend continued on next page)
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time-lapse single-cell imaging of E14/TOP-dGFP showed switch-
ing on and off of the reporter over time, as well as fluctuations
between the two states (Movie S4; Figures 4F and S4E).
Finally, the TOP-dGFP reporter was activated 3 days after
culturing FACS-sorted GFP population in 2i+LIF, while it was
inactivated in sorted GFP+ cells (Figure 4G). Target genes
were active only in the sorted GFP+ cells, while Nanog did not
change in both populations (Figure 4H).
Overall, these data indicate that b-catenin and its target genes
can fluctuate in ground pluripotency state.
DISCUSSION
Crosstalk between the Wnt/b-catenin pathway and Nanog is
important for ESC physiology. Here, we show that Nanog re-
presses an important negative regulator of the Wnt pathway,
Dkk1, and in turn indirectly activates b-catenin. This is essential
for the function of Nanog during somatic cell reprogramming. On
the other hand, we cannot exclude additional regulation by
Nanog of other effectors of the pathway or that repression of
Dkk1 by Nanog is in cooperation with a recruited repressor com-
plex. Impairment of reprogramming due to lack of Nanog can be
rescued by b-catenin stabilization, which implies a key function
of b-catenin as a downstream effector of Nanog. Interestingly,
there have been similar findings for Esrrb (Festuccia et al.,
2012; Martello et al., 2012) and Tet1 and Tet2 (Costa et al.,
2013), which are also Nanog-dependent factors in the establish-
ment of pluripotency and reprogramming.
The regulation of Nanog on b-catenin in the reprogramming
process is relevant regardless of transcriptional (Nusse, 2008;
ten Berge et al., 2011) and nontranscriptional activities of b-cat-
enin (Faunes et al., 2013), which might be synergistic, and there-
fore may be both important in the control of ESC pluripotency.
We used b-catenin null ESCs and confirmed published data
(Lyashenko et al., 2011; Wray et al., 2011) that in the presence
of LIF, these cells maintain pluripotency. Other studies have re-
ported that removal of b-catenin affects pluripotency (Faunes
et al., 2013). These divergences are probably due to the different
strategies used to generate the lines.
Nanog is heterogeneous in serum+LIF, but only under feeder-
free conditions,while it is homogeneous in 2i+LIFmedium (Cahan
and Daley, 2013; Smith, 2013), although some variability is ex-
pected (Faddah et al., 2013). Nanog dynamics were modeled
as a single, stable, and high steady state, from which ESCs can
escape due to intrinsic noise toward a transient state with low
Nanog expression, in an excitable fashion (Kalmar et al., 2009).
High and low Nanog states were also shown equally probable,
and the dynamics of the transition between these as monotonic
(Abranches et al., 2013). Here, we included Dkk1 and b-catenin
and demonstrated that Nanog and b-catenin fluctuate synchro-
nously with bistable dynamics due to stochastic noise.
Interestingly, in 2i+LIF medium, b-catenin fluctuates indepen-
dently of Nanog. Fluctuations are probably regulated by negative
feedback loops that result in Wnt pathway activation (Lee et al.,
2003), as the 2i medium contains Chiron.
Nanog-dependent fluctuations are stochastic and are due to
transcriptional noise; they might be important to prime cells
toward differentiation. Upon Wnt pathway activation, fluctuating
dynamics of b-catenin are not stochastic, as they can be
controlled by negative feedback loops induced by drug treat-
ments. Whether controlled b-catenin dynamics can maintain
the ground state of ESC pluripotency remains an open question.
EXPERIMENTAL PROCEDURES
Cell Hybrids
For ESC and neural precursor cell (NPC) cocultures, 1.0 3 106 ESCs were
plated onto preplated 1.0 3 106 NPCs. These were cocultured for 4 hr, first
for 2 hr in NPC medium and then for 2 hr in ESC medium. The cells were
then trypsinized and plated at 1/5 into p100 gelatin-coated dishes in ESC
medium. After 72 hr, puromycin or hygromycin were added to the ESCmedium
for hybrid selection.
Time-Lapse Live Fluorescence Imaging
Images were acquired with a 403 (numerical aperture 0.55) lens using 488 nm
and 561 nm excitation. A pinhole size of 3 Airy units was used to increase
signal. Cells were imaged at 37C in a humidified environmental chamber in
5%CO2. A time interval of 1 hr was set between time points. Image processing
and fluorescence quantification were performed using ImageJ v1.47p.
Mathematical Model Simulation and Analysis
The stability and bifurcation analyses were realized using the software
tool xppaut (http://www.math.pitt.edu/bard/xpp/xpp.html). To approximate
numerical solutions of the stochastic differential equations, we applied the
Euler-Maruyama method. Stochastic simulations were implemented using
the programming language C++. Density plots were generated under the
MATLAB platform (MathWorks).
SUPPLEMENTAL INFORMATION
Supplemental information includes Supplemental Experimental Procedures,
four figures, one table, and four movies and can be foundwith this article online
at http://dx.doi.org/10.1016/j.celrep.2014.08.011.
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Figure S1. Tagging of β-catenin in mouse ESCs and mESCs characterization. 
Related to Figure 1.  
(A) qPCR of Nanog expression in E14Tg2a and EF4 cells. (B) qPCR of Nanog 
mRNA in EF4 cells treated with Dkk1, with IWP2 or left untreated. (C) Western blot 
of total β-catenin in EF4 cells untreated or treated with recombinant Dkk1. (D) 
qPCR of the β-catenin target genes in EF4 cells untreated or treated with IWP2. (E) 
Schematic model showing designed zinc fingers aligned to their target DNA just 
upstream of the β-catenin start codon (ATG; green). Arrows indicate canonical base 
contacts. Zinc finger α-helix sequences that are involved in DNA recognition, are 
indicated (F1, Finger 1, etc.). The FokI moities are shown as positively (+) or 
negatively (-) charged to allow obligate heterodimer formation. The nuclease cutting 
region is in red. Part of the genomic DNA codes for a protein linker to β-catenin in 
the final eGFP fusion (HSCCDTAAWTM). (F) Donor DNA design indicating the 
homology arms that match the DNA between the donor plasmid and the genomic 
region. (G) Scheme of the GFP-β-catenin fusion protein. The tagging is at the N-
terminus. (H) PCR amplification of the tagged allele using genomic DNA of EL55 
cells. (I) qPCR of pluripotency genes in EL55 cells. (J) Immunofluorescence of total 
β-catenin and GFP in EL55 cells cultured in serum+LIF medium and correlation plot 
of β-catenin and GFP in EL55 cells (r is the Pearson correlation coefficient).  
Segmented images and identified objects are shown. (K) Co-immunofluorescence of 
GFP- β-catenin and endogenous β-catenin with EEA1 (early endosome) in EL55 
cells cultured in serum+LIF medium.  (L) Western blot of total β-catenin using 
cytosolic and nuclear extracts of EL55 cells after 1 day of CHIR99021 treatment (3 
μM). E-cadherin is used as negative control for nuclear extracts. Tubulin and Histone 
H2B were used as housekeeping genes for cytosolic and nuclear extracts, respectively. 
(M) qPCR of Axin2 and Cdx1 upon CHIR99021 treatment. (N) Western blot of β-
catenin and Nanog in wild-type ESCs (RF8 cells) and in Nanog-null cells (β
geo/Hygro) untreated or treated for 1 week with Meki (PD184352; 3 µM).  Data are 
means ±SEM (n = 3). p >0.1, *, p <0.05, **, p <0.01, ***, p <0.0001. Scale bar, 25 
μm. 
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Figure S2. Characterization of wild type and mutant mESCs and of 
reprogramming experiments, Related to Figure 2.  
(A) Representative images of AP staining of clones obtained after spontaneous cell 
fusion between NPCs and E14Tg2a, EF4 and EF4 cells pretreated with Dkk1. (B) 
NPCs were co-cultured with E14Tg2a or with EF4 or with Dkk1-treated EF4 for 4 
hours. The percentage of the hybrids was evaluated by FACS analysis. Representative 
FACS profiles of the hybrids are shown. (C) Western blot of Dkk1 after the infection 
of wild type E14Tg2a ESCs with ShRNA Control and ShRNA against Dkk1.  (D) 
Western blot of total β-catenin after infection of E14Tg2a ESCs with ShRNA Control 
and ShRNA against Dkk1. (E) Dkk1, Axin2 and Nanog expression in ESCs infected 
with ShRNA against Dkk1.  (F-H) Activation of the Wnt pathway by silencing Dkk1 
increases the reprogramming efficiency. (F) Representative images of AP staining. (G 
and H) Quantification of reprogramming efficiency, counting AP+ (G) and GFP+ (H) 
colonies. (H, inset) Representative GFP clone. (I) qPCR of Nanog in Nanog 
overexpressing N1 (β-catenin fl/fl) and ΔN4 (β-catenin Δ/Δ) cell lines. (J) Expression 
of β-catenin target genes in N1 cells, ΔN4 cells and their parental lines. (K) 
Representative images of AP staining of clones obtained after spontaneous cell fusion 
between NPCs and β-catenin fl/fl, β-catenin Δ/Δ, ΔN4 and N1 ESCs. (L-P) 
Characterization of β-catenin null ESCs and their parental lines. (L) Bright field 
microphotograph of wild type β-catenin and β-catenin null ESCs. (M and N) qPCR 
and western blot of the pluripotency genes and Plakoglobin in wild type fl/fl β-
catenin and Δ/Δ β-catenin ESCs (Lyashenko et al., 2011) as well as in wild type fl/-
β-catenin and Δ/- β-catenin ESCs (Wray et al., 2011)  cultured in serum+LIF 
medium. (O) Immunofluorescence of E-cadherin and Plakoglobin in wild type and β
-catenin null ESCs as indicated in B and C cultured in serum+LIF medium. (P) 
Percentage of hybrids analyzed by FACS after 4h of co-culture of NPCs with β-
catenin fl/fl or β-catenin Δ/Δ ESCs. Representative FACS profiles of the hybrids 
are shown. (Q) qPCR of Esrrb in EF4 ±Dkk1, β-catenin fl/fl and β-catenin Δ/Δ. 
(R) qPCR of Wnt3a expression in EF4 and ΔN4  cells. (S) qPCR of Wnt3a expression 
upon CHIR99021 treatment of RF8 and of Nanog βgeo/+ cells (treated vs untreated). 
(T) Western blot of total β-catenin in wild-type ESCs (RF8 cells) and in cells lacking 
one copy of Nanog (Nanog βgeo/+ cells) upon CHIR99021 treatment. (U) qPCR of 
β-catenin target genes and Nanog in RF8 and Nanog βgeo/+ cells upon the 
activation of the pathway with CHIR9902 (treated vs untreated). (V) Representative 
images of AP staining (spontaneous cell fusion between NPCs and RF8 or	  βgeo/+ 
ESCs untreated, or treated for 24 h with Chiron  3 μM). (W) Immunofluorescence of 
E-cadherin and Plakoglobin in RF8 and Nanog βgeo/+ cells cultured in serum+LIF 
medium. (X) Western blot of E-cadherin and Plakoglobin in RF8 and Nanog βgeo/+ 
cells cultured in serum+LIF medium. (Y) Percentage of hybrids analyzed by FACS 
after 4h of co-culture of NPCs with RF8 or Nanog βgeo/+ cells. Representative 
FACS profiles of the hybrids are shown. (Z-B|) Stabilization of β-catenin levels using 
recombinant Wnt3a (48 h, 200ng/mL) does not rescue the reprogramming deficiency 
of cells lacking one copy of Nanog (βgeo/+). (Z) Representative images of AP 
staining. (A| and B|) Quantification of reprogramming efficiency, counting AP+ (A|) 
and GFP+ (B|) colonies. (B|, inset) Representative GFP clone. (C|) qPCR of the β-
catenin target genes in RF8 and Nanog βgeo/+ cells upon the activation of the 
pathway with recombinant Wnt3a (treated vs untreated). (D|) Immunofluorescence of 
Nanog and SSEA-1 in pre-iPSCs generated from MEFsNanog-GFP. (E|) Expression of 
Wnt target genes analyzed by qPCR in pre-iPSCsNanog-GFP grown in ESC medium, and 
ESC medium supplemented with Meki (PD0325901) ±Dkk1. (F|) qPCR of pre-iPSCs 
Nanog-GFP and iPSCs Nanog-GFP to analyse the reactivation of stem cell specific genes. (G|) 
Teratoma formed after injection of iPSCs Nanog-GFP were stained with H&E to identify 
tissues coming from different germ layers. (H|) Immunofluorescence staining for 
Nestin (marker of ectoderm lineage), Smooth Muscle Actin (SMA, marker of 
mesoderm lineage) and FoxA2 (marker of endoderm lineage) using teratoma sections. 
(I|) General scheme of iPSC generation protocol. Pre-iPSCsNanog-GFP(Nanog- and 
SSEA-1+) were infected with a lentiviral vector containing Nanog coding sequence. 
Drug selected clones were switched to ESC medium ±Dkk1 (50ng/mL). (J|) iPSCs 
were analyzed for Nanog and Oct4 expression by immunofluorescence. (K|) 
Percentage of fully reprogrammed Nanog-GFP+ iPSCs over total pre-iPS clones. (L|) 
Pre-iPSCs β-cat fl/flcharacterization by immunofluorescence of SSEA-1, β-catenin and 
Nanog. (M|) Western blot of total β-catenin using extracts of pre-iPSCs β-cat fl/fl 
±tamoxifen. (N|) Pre-iPSCs β-cat fl/fl treated with tamoxifen and grown in ESC medium 
plus Meki were stained for Nanog, Oct4, SSEA-1 and	  β-catenin. (O|)	   Pre-iPSCs 
grown in ES medium without tamoxifen but in presence of Meki, converted into 
iPSCs, were characterized by immunofluorescence. Data are means ±SEM (n = 3).  p 
>0.1, *, p <0.05, **, p <0.01, ***, p <0.0001. Scale bar, 25 μm (L, O, W, D|, H|, J|, L|, 
N| and O|). Scale bar, 100 μm (G|). Scale bar, 200 μm (H, inset and B|, inset). The 
immunofluorescence images in D|, G|, H|, J|, L|, N| and O| were collected using a not 
confocal inverted microscope.  
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Figure S3. Fluctuations of β -catenin and Nanog in mESCs cultured in 
serum+LIF medium, Related to Figure 3.  
(A and B) qPCR of pluripotency genes and immunofluorescence of Oct4 and GFP 
using FACS-sorted Lβ -cat (GFP-) and Hβ -cat (GFP+) EL55 cells. (C) 
Quantification of the GFP signal normalized against the H2B-RFP signal in single cell 
time lapse imaging of EL55 cells cultured in serum+LIF medium. Switch on and off 
are shown. (C, right) Pluripotency of EL55 cells cultured in serum+LIF was not 
affected by laser exposure in cells analyzed at the end of time-lapse experiments by 
Nanog immunostaining. (D) Schematic representation of the Oct4/Sox2 heterodimer 
autoregulation. (E) ESCs were treated with cycloheximide (50 µM CHX) for 12 h, 
and the pelleted cells were analyzed by Western blotting. (F) Quantifican from 
Western blots. β-catenin protein levels were calculated by normalizing against actin. 
Dashed lines indicate β-catenin half-life.  Data are means ±SEM (n = 3), p >0.1. 
Scale bar, 25 μm (B). Scale bar, 200 μm (C, right). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0!
0.5!
1!
1.5!
2!
2.5!
0! 4! 8! 12! 16! 20!
0!
0.5!
1!
1.5!
0! 4! 8! 12! 16!
GF
P 
/ R
FP
([a
.u
.])
!
!
EL55 2i+LIF!
(Switch ON)!
Time (Hours)!
GF
P 
/ R
FP
([a
.u
.])
!
!
Time (Hours)!
EL55 2i+LIF!
(Oscillation)!
0!
0.5!
1!
1.5!
2!
2.5!
0! 4! 8! 12! 16!
GF
P 
/ R
FP
([a
.u
.])
!
!
Time (Hours)!
EL55 2i+LIF!
(Switch OFF)!
C!
E14/TOP-dGFP time-course!
2i+LIF!
0h! 12h! 24h! 48h!
D!
GFP!
GFP+!
5.7%!
GFP+!
10%!
GFP+!
4.6%!
GFP+!
2.6%!
36h!
GFP+!
7.1%!
0!
1!
2!
3!
0! 4! 8! 12! 16!
0!
0.1!
0.2!
0.3!
0.4!
0.5!
0! 4! 8! 12! 16!
GF
P 
/ R
FP
([a
.u
.])
!
!
E14/TOP-dGFP 2i+LIF !
(Switch ON)!
Time (Hours)!
E14/TOP-dGFP 2i+LIF !
(Switch OFF)!
Time (Hours)!
GF
P 
/ R
FP
([a
.u
.])
!
!
E!
0!
1!
2!
3!
4!
0! 4! 8! 12! 16!
GF
P 
/ R
FP
([a
.u
.])
!
!
Time (Hours)!
E14/TOP-dGFP 2i+LIF !
(Oscillation)!
0!
0.5!
1!
1.5!
2!
2.5!
3!
3.5!
4!
4.5!
0! 0.5! 1! 1.5! 2! 2.5! 3! 3.5! 4! 4.5!
β-
ca
t/G
FP
-ta
g 
[a
.u
]!
!
β-cat [a.u]!
EL
55
!
2i+
LI
F!
A!
β-cat GFP"β-cat" β-cat/GFP-tag" DAPI β-cat GFP"
Segmentation!
Id. objects!
 r =0.98!
B!
0!
1!
2!
3!
4!
5!
0! 2! 4! 6! 8! 10! 12!
GF
P 
/ R
FP
([a
.u
.])
!
(E
L5
5 
2i+
LI
F)
!
Time (Hours)!
Movie S3"
Figure S4. Fluctuations of β-catenin and Nanog in mESCs cultured in 2i+LIF, 
Related to Figure 4.  
(A) Immunofluorescence of total β-catenin and GFP in EL55 cells cultured in 2i+LIF 
medium and correlation plot of β-catenin and GFP in EL55 cells (r is the Pearson 
correlation coefficient).  Segmented images and identified objects are shown. (B) 
Snapshots of the movie S3 of EL55 cells cultured in 2i+LIF medium with relative 
quantification of the GFP signal normalized against the H2B-RFP signal. Yellow 
arrows indicate GFP switch on. (C) Quantification of the GFP signal normalized 
against the RFP in single cell time lapse imaging of EL55 cells cultured in 2i+LIF 
medium. Switch on, switch off and oscillations are shown. (C, right) Pluripotency of 
EL55 cells cultured in 2i+LIF was not affected by laser exposure in cells analyzed at 
the end of time-lapse experiments by Nanog immunostaining. (D) Representative 
FACS analysis of 48 hours time-course experiment of unsorted E14/TOP-dGFP 
grown in 2i+LIF. (E) Quantification of the GFP signal normalized against the H2B-
RFP signal in single cell time lapse imaging of E14/TOP-dGFP cells cultured in 
2i+LIF medium. Switch on, switch off and oscillations are shown. (E, right) 
Pluripotency of E14/TOP-dGFP cells cultured in 2i+LIF was not affected by laser 
exposure in cells analyzed at the end of time-lapse experiments by Nanog 
immunostaining. Data are means ±SEM (n = 3). Scale bar, 25 μm (A). Scale bar, 200 
μm (C, inset and E, inset).  
 
 
 
 
 
 
 
 
 
 
 
Supplemental Table 1. Parameters of the mathematical model; cell lines used in 
the present study; list of primers. 
 
Supplemental Movies.  β-catenin fluctuations in single cell live imaging, Related 
to Figures 3 and 4.  
Movie S1. Time-lapse of the EL55 cells in serum+LIF medium. White arrow 
indicates GFP switch-off while the yellow arrow GFP indicates switch-on. 
Movies S2 and S3. Time-lapses of the EL55 cells in 2i+LIF medium.  White arrow 
indicates GFP switch-off while the yellow arrow indicates GFP switch-on.  
Movie S4. Time-lapses of E14/TOP-dGFP cells in 2i+LIF medium. Yellow arrow that 
becomes white indicates an oscillation of the GFP signal while the yellow arrow from 
frame 4 onward indicates GFP switch-on. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
EXTENDED EXPERIMENTAL PROCEDURES 
 
Cell lines 
ESCs were cultured on gelatin in knockout Dulbecco’s modified Eagle’s medium 
(DMEM) supplemented with 20% fetal bovine serum (Hyclone), 1 x nonessential 
amino acids, 1 x GlutaMax, 1 x 2-mercaptoethanol, and 1000 U/ml LIF ESGRO 
(Millipore).  NPCs-Oct4-puro (kind gift of A. Smith) and TNGA ESCs (kind gift of I. 
Chambers) were generated and cultured as previously described (Chambers et al., 
2007; Conti et al., 2005). NPCs-Oct4-puro cells were further modified by inserting the 
hygromycin-resistance gene under a constitutive promoter (pCAG). Cells were 
selected to create stable clones expressing the hygromycin-resistance gene. E14Tg2a 
and EF4 ESCs (kind gift of I. Chambers) were cultured as previously described 
(Chambers et al., 2003). The ESC mutants N1 and ∆N4 were derived from wild-type 
ESCs (β-catenin fl/fl) and β-catenin Δ/Δ cells, kind gift of C. Hartmann (Lyashenko 
et al., 2011). They were clonally isolated after nucleofection (Amaxa) of the pCAG-
Nanog (kind gift of I. Chambers) and selected with puromycin. Wild-type RF8 ESCs, 
kind gift of R. Farese, were described in (Meiner et al., 1996). Nanog βgeo/+ cells and 
Nanog βgeo/Hygro (kind gift of S. Yamanaka) were genetically derived as previously 
described (Mitsui et al., 2003).  
EL55 ESCs (Sv/129 background) were obtained by inserting a GFP-tag in the 
endogenous β-catenin locus gene using Zinc Finger technology (Isalan et al., 2001). 
The EL55 clone was selected for GFP integration via single cell sorting by FACS. 
Sorted GFP-positive cells were then expanded and genomic DNA was used to identify 
the clones in which GFP had recombined with the endogenous β-catenin gene. E14- 
TOP-dGFP cells were clonally isolated from wild-type E14Tg2a cells nucleofected 
with a TOP-dGFP plasmid (destabilized GFP was inserted in the 7TGP plasmid 
(Addgene) to replace the original enhanced GFP), and drug selected. 
Cells used in time-lapse experiments (EL55 and E14-TOP7x-dGFP) were stably 
nucleofected with pHIV-H2BmRFPplasmid purchased from Addgene (Plasmid 
18982) (Welm et al., 2008) carrying a H2BmRFP sequence. 
Dkk1	   was	   silenced	   by	   infecting	   cells	   with	   viral	   ShRNA	   against	   Dkk1	   (Sigma,	  MISSION	   shRNA,	   TCR	   number	   TRCN0000055155,	   clone	   ID	   NM_010051.2-­‐228s1c1)	   and	   with	   ShControl	   (pLKO.1	   puro,	   Sigma).	   Infected	   cells	   were	   drug	  selected	  for	  the	  integration	  of	  the	  virus	  before	  fusion	  experiment.	  	  
 
Drug treatments 
EF4 cells (1.0 x106 ) were plated on gelatin and treated for 24 h with 50 ng/mL Dkk1 
recombinant protein (R&D Systems).  IWP2 (Stemgent) was used at 2 μM, during 24 
hour treatment. RF8 cells (1.0 x106) and Nanog βgeo/+ cells (1.0 x106 ) were plated 
on gelatin and treated for 24 h with CHIR99021(3 μM) (Selleck Chemicals) (Bain	  et	  al.,	  2007).  Similarly, recombinant Wnt3a protein (R&D) was used at 200 ng/ml (48 
hours treatment). Twenty-four hours later, cells were trypsinized, counted and plated 
on NPCs for fusion, or harvested for RNA and protein analyses. Fusions and drug 
selection were performed as described in the Cell hybrids protocol. For the fusion of 
RF8 and Nanog βgeo/+ cells, the hybrids were treated additionally for 72 h with 
CHIR99021 before starting drug selection. 
EL55 and ESC-TNGA cells were treated with 3 μM CHIR99021 and 3 μM Mek 
inhibitor (PD184352, Sigma) (Davies	  et	  al.,	  2000)	  for 1 day and 7 days, respectively. 
After each treatment cells were collected and analyzed by flow cytometry. PD184352 
was refreshed every 48 hours. 
 
Western blotting  
Western blotting was performed as previously described (Zito et al., 2007). The 
primary antibodies used were: anti-β-catenin, clone 14 (BD Biosciences), working 
concentration 1:1000; anti-Nanog (CALBIOCHEM), working concentration 1:1000; 
anti-β-actin (Abcam), working concentration 1:2000; anti-GFP (Santa Cruz 
Biotechnology), working concentration 1:500; anti-Dkk1 (Santa Cruz Biotechnology), 
working concentration 1:100; anti-Plakoglobin (BD Biosciences), working 
concentration 1:1000; anti E-Cadherin (BD Biosciences), working concentration 
1:1000; anti-Oct3/4 (Santa Cruz Biotechnology), working concentration 1:1000. The 
secondary antibodies were diluted 1:3000. 
Immunostaining 
Cells were washed twice with phosphate-buffered saline (PBS), fixed with 4% 
paraformaldehyde for 15 min at RT, and blocked in PBS with 0.3% Triton  X-100 and 
10% goat serum, for 60 min.  The cells were incubated with the specific primary 
antibodies for 4 h, and 1 h with the secondary antibody conjugated with fluorescein. 
The cells were then washed and mounted on slides with a few drops of Vectashield, 
with DAPI (Vector Laboratories).  
The primary antibodies used for immunostaining were: anti-β-catenin, clone 14 (BD 
Biosciences), working concentration 1:1000; anti-active-β-catenin (ABC), working 
concentration 1:400, clone 8E7 (Millipore); anti-GFP (Santa Cruz Biotechnology), 
working concentration 1:1000; anti-SSEA-1, clone 480 (Santa Cruz Biotechnology), 
working concentration 1:500; anti-Nanog (CALBIOCHEM), working concentration 
1:500; anti-Oct3/4, clone C10 (Santa Cruz Biotechnology), working concentration 
1:1000; anti-Nestin (Abcam), working concentration 1:200; anti-FoxA2 (ab40874 
Abcam), working concentration 1:400; anti-Smooth-Muscle-Actin (SMA, Sigma), 
working concentration 1:400; anti-Plakoglobin (BD Biosciences), working 
concentration 1:400; anti E-Cadherin (BD Biosciences), working concentration 1:400; 
anti-EEA1 (BD Biosciences), working concentration 1:50. The fluorescent conjugated 
secondary antibodies were diluted 1:1000. 
 
Immunostaining quantification and correlation analysis 
To indentify single-cell (segmentation) in immunostainings, we implemented an 
automated methodology using CellProfiler (Carpenter et al., 2006).  The designed 
pipeline detects nuclei from DAPI, propagates nuclei to indentify cytoplasm, quantify 
fluorescence on the indentified objects (pipeline available upon request). Over-
segmented or under-segmented objects were removed manually where needed. Line 
plot distribution, scatterplots and Pearson correlation coefficient were generated using 
Excel. 
 
qPCR 
For quantitative PCR, the total RNA was extracted from mouse ESCs, MEFs, Pre-
iPSCs and iPSCs using the RNeasy kit (Qiagen), and the cDNA was generated from 1 
μg of RNA using Superscript III (Invitrogen). For cDNA 25 ng was used as template 
for each reaction, in a10 μl reaction volume. LightCycler 480 SYBR Green I Master 
(Roche) was used with LightCycler®480 System (Roche).  
 
Chromatin immunoprecipitation assay 
Chromatin immunoprecipitation (ChIP) was carried out using the protocol described 
in (Morey et al., 2012). ESCs were trypsinised and crosslinked in 1% formaldehyde 
for 10 min at room temperature. The crosslinking was quenched with 0.125 M glycine 
for 5 min. The pelleted cells were lysed in 1 ml ChIP buffer and sonicated for 10 min 
in a Bioruptor sonicator (Diagenode). The soluble material was quantified using 
Bradford assays. To immunoprecipitate the transcription factors, 1mg protein was 
used, and 5 μg anti-Nanog (BETHYL laboratories) and 5 μg IgG were incubated 
overnight with the chromatin. The immunocomplexes were recovered with 30 μl 
protein A or G agarose bead slurries. The immunoprecipitated material was washed 
three times with a low-salt buffer, and one time with a high-salt buffer. DNA 
complexes were decrosslinked at 65 °C for 3 h, and the DNA was then eluted in 200 
μl water using the PCR purification kit (QIAGEN). Two microliters DNA was used 
for each qPCR reaction.  
 
FACS analysis and cell sorting 
After CHIR99021 and Mek inhibitor treatment, the untreated and treated ESCs were 
trypsinized and the pelleted cells were resuspended in PBS with 2% FBS with DAPI. 
The endogenous GFP of the EL55 and TNGA cells was analysed using a BD LSR 
Fortessa. For FACS sorting, cells were prepared in the same way and sorted on a BD 
FACS aria II. To check cell fusion efficiency, NPCs and ESCs were stained with Mito 
Tracker, from Invitrogen, green (300 nM) and orange (150 nM) respectively, and 
incubated at 37°C for 30 min. The day after, green NPCs and orange ESCs were co-
cultured as described in the cell hybrids section. Mito Tracker signal was analyzed 
using a BD LSR Fortessa 4 hours after fusion.  
EL55 cell generation with zinc finger technology 
A genomic target region was chosen to provide a G-rich, stop-codon free, in-frame 
sequence, close to the N-terminus of β-catenin. Zinc fingers were designed rationally 
with the help of ZiFit (Sander et al., 2012). DNA recognition helix design was guided 
by (Isalan et al., 2001). To form functional obligate heterodimer zinc finger nucleases 
(ZFNs), DNA for zinc finger proteins (ZFPs) was synthesised and cloned via 
XbaI/BamHI into pMLM290/pMLM292 expression plasmids (Miller et al., 2007), 
(http://www.addgene.org/21873/ and http://www.addgene.org/21872/).  
 
ZFP-FokI DNA coding sequences (Zinc finger a-helices underlined): 
>bCat_1LEFT_3F_pMLM290 
ATGGGACCTAAGAAAAAGAGGAAGGTGGCGGCCGCTGACTACAAGGATG
ACGACGATAAATCTAGACCCGGGGAGCGCCCCTTCCAGTGTCGCATTTGC
ATGCGGAACTTTTCGACCACCGGCGCCCTGACCGAACATACCCGTACTCA
TACCGGTGAAAAACCGTTTCAGTGTCGGATCTGTATGCGAAATTTCTCCCG
CAGCTCCAACCTGACCAGGCATCTACGTACGCACACCGGCGAGAAGCCAT
TCCAATGCCGAATATGCATGCGCAACTTCAGTCAGAGCTCCGACCTGACC
CGCCACCTAAAAACCCACCTGAGGGGATCCCTAGTCAAAAGTGAACTGGA
GGAGAAGAAATCTGAACTTCGTCATAAATTGAAATATGTGCCTCATGAAT
ATATTGAATTAATTGAAATTGCCAGAAATTCCACTCAGGATAGAATTCTTG
AAATGAAGGTAATGGAATTTTTTATGAAAGTTTATGGATATAGAGGTAAA
CATTTGGGTGGATCAAGGAAACCGGACGGAGCAATTTATACTGTCGGATC
TCCTATTGATTACGGTGTGATCGTGGATACTAAAGCTTATAGCGGAGGTTA
TAATCTGCCAATTGGCCAAGCAGATGAAATGCAACGATATGTCAAAGAAA
ATCAAACACGAAACAAACATATCAACCCTAATGAATGGTGGAAAGTCTAT
CCATCTTCTGTAACGGAATTTAAGTTTTTATTTGTGAGTGGTCACTTTAAA
GGAAACTACAAAGCTCAGCTTACACGATTAAATCATAAGACTAATTGTAA
TGGAGCTGTTCTTAGTGTAGAAGAGCTTTTAATTGGTGGAGAAATGATTA
AAGCCGGCACATTAACCTTAGAGGAAGTGAGACGGAAATTTAATAACGGC
GAGATAAACTTTTAA 
 
>bCat_1RIGHT_pMLM292 
ATGGGACCTAAGAAAAAGAGGAAGGTGGCGGCCGCTGACTACAAGGATG
ACGACGATAAATCTAGACCCGGGGAGCGCCCCTTCCAGTGTCGCATTTGC
ATGCGGAACTTTTCGCGCAGCGACGCCCTGACCAGGCATACCCGTACTCA
TACCGGTGAAAAACCGTTTCAGTGTCGGATCTGTATGCGAAATTTCTCCCA
GAGCTCCGACCTGAGCCGCCATCTACGTACGCACACCGGCGAGAAGCCAT
TCCAATGCCGAATATGCATGCGCAACTTCAGTCAGAGCTCCGACCTGACC
CGCCACCTAAAAACCCACCTGAGGGGATCCCAACTAGTCAAAAGTGAACT
GGAGGAGAAGAAATCTGAACTTCGTCATAAATTGAAATATGTGCCTCATG
AATATATTGAATTAATTGAAATTGCCAGAAATTCCACTCAGGATAGAATT
CTTGAAATGAAGGTAATGGAATTTTTTATGAAAGTTTATGGATATAGAGG
TAAACATTTGGGTGGATCAAGGAAACCGGACGGAGCAATTTATACTGTCG
GATCTCCTATTGATTACGGTGTGATCGTGGATACTAAAGCTTATAGCGGAG
GTTATAATCTGCCAATTGGCCAAGCAGATGAAATGGAGCGATATGTCGAA
GAAAATCAAACACGAAACAAACATCTCAACCCTAATGAATGGTGGAAAG
TCTATCCATCTTCTGTAACGGAATTTAAGTTTTTATTTGTGAGTGGTCACTT
TAAAGGAAACTACAAAGCTCAGCTTACACGATTAAATCATATCACTAATT
GTAATGGAGCTGTTCTTAGTGTAGAAGAGCTTTTAATTGGTGGAGAAATG
ATTAAAGCCGGCACATTAACCTTAGAGGAAGTGAGACGGAAATTTAATAA
CGGCGAGATAAACTTTTAA 
 
ZFN Protein Sequences  
Zinc finger a-helices are underlined. Sequences include FokI (positively or negatively 
charged) from pMLM290/pMLM292, N-terminal Nuclear Localisation Signals (NLS) 
and FLAG-tag: 
>bCat_1LEFT_3F_pMLM290-FokI+ 
MGPKKKRKVAAADYKDDDDKSRPGERP 
FQCRICMRNFSTTGALTEHTRTHTGEKP 
FQCRICMRNFSRSSNLTRHLRTHTGEKP 
FQCRICMRNFSQSSDLTRHLKTHLRGS 
LVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVYG
YRGKHLGGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMQRYV
KENQTRNKHINPNEWWKVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHKTN
CNGAVLSVEELLIGGEMIKAGTLTLEEVRRKFNNGEINF* 
>bCat_1RIGHT_pMLM292-FokI- 
MGPKKKRKVAAADYKDDDDKSRPGERP 
FQCRICMRNFSRSDALTRHTRTHTGEKP 
FQCRICMRNFSQSSDLSRHLRTHTGEKP 
FQCRICMRNFSQSSDLTRHLKTHLRGS 
QLVKSELEEKKSELRHKLKYVPHEYIELIEIARNSTQDRILEMKVMEFFMKVY
GYRGKHLGGSRKPDGAIYTVGSPIDYGVIVDTKAYSGGYNLPIGQADEMERY
VEENQTRNKHLNPNEWWKVYPSSVTEFKFLFVSGHFKGNYKAQLTRLNHIT
NCNGAVLSVEELLIGGEMIKAGTLTLEEVRRKFNNGEINF* 
 
iPSC generation  
Pre-iPSCs were generated by retroviral infection of MEFs with pMXs-based 
containing the four factors: Oct4, Sox2, c-Myc and Klf4 obtained from Addgene, Inc. 
The plasmids containing the four factors were transfected into the Platinum-E 
Retroviral Packaging cell line, Ecotropic from Cell Biolabs Inc packaging cell line 
(ref.RV-101) using the CalPhosTM Mammalian Transfection kit from Clontech 
Laboratories, Inc. (ref.631312). Then 48 hours before transfection, 5 x104 murine 
embryonic fibroblasts (MEFs) were seeded in each well of a 6-well plate. The virus-
containing supernatants were supplemented with 4 mg/ml of polybrene. Equal 
amounts of viral supernatants containing each of the 4 retroviral vectors were mixed, 
added to the MEFs and incubated overnight. The cells were treated with the viral 
supernatants two more times. At 48 h after the last infection, the cells were switched 
to ESC medium supplemented with 1,000 U/ml of leukemia inhibitory factor (LIF). 
Two days after switching the medium, the infected fibroblasts were harvested by 
trypsinization and each well was replated into a 100-mm dish on MEF feeder layers. 
The medium was replaced every day.  
Pre-iPSCs from MEFs purified from a Nanog-GFP mouse strain (Tg(Nanog-
GFP,Puro)1Yam, Riken), were switched into ESC medium plus MEK Inhibitor 
(PD0325901, Selleck Chemicals, 1 μM) containing or not Dkk1 recombinant protein. 
Seven days after switching medium, iPSCs (Nanog-GFP positive) were counted. 
Pre-iPSCs from MEFs purified from a Nanog-GFP mouse strain (Tg(Nanog-
GFP,Puro)1Yam, Riken) were infected with pBABE-Nanog-Hygro virus (Nanog 
coding sequence was cloned into pBABE-Hygro plasmid, purchased by Addgene) or 
with PBabe-Hygro virus as control. Infected cells were selected for the virus 
integration for three days. After three additional days, Dkk1 was added or not to ESC 
medium, and five days later iPSCs (Nanog-GFP positive) were counted. 
Pre-iPSCs from MEFs purified from the B6.129-Ctnnb1tm2Kem/KnwJ/β-Actin-CRE 
mouse strain (β-catenin conditional KO, inducible with tamoxifen from Jackson 
Laboratories) were treated with 1 μM tamoxifen (Sigma) for 48 h, to excide the β-
catenin gene and then switched to ESC medium containing MEK inhibitor 
(PD0325901, Selleck Chemicals, 1 μM) to promote iPSCs formation by Nanog 
overexpression. Control plates were incubated for 48 h with ethanol (vehicle for 
tamoxifen). Eight days after switching the medium, iPSCs Nanog+ were counted.  
 
ELISA assay 
Dkk1 dosage was carried out using the Quantikine mouse Dkk-1 Immunoassay from 
R&D (MKK100). Cell culture supernatant collected from wild-type ESCs and mutant 
ESCs was incubated with the appropriate antibodies according to the manufacturer. A 
standard curve was generated plotting on the y-axis the optical density of each 
standard and on the x-axis the relative concentration. Dkk1 concentration in pg/mL 
was calculated fitting the calibration curve. 
 
Teratoma production  
Cells were trypsinized into single-cell suspensions and resuspended in phosphate-
buffered saline to a concentration of 1.5 x107 cells/mL. These cells were injected 
subcutaneously into Fox Chase SCID mice using a 25 gauge needle (200 ml). 
Teratomas were collected after 4 weeks and were fixed, embedded, sectioned, and 
stained for Nestin (1:200), FoxA2 (1:400) and SMA (1:400). 
 
Mathematical model derivation 
The mathematical model is composed of four differential equations for the Oct4/Sox2, 
Nanog, Dkk1 and β-catenin concentrations. They are derived from stoichiometric 
equations for transcription factors binding to the genes.  The main assumptions of the 
model are: (a) the concentration of the Oct4 and Sox2 heterodimer is in dynamic 
equilibrium with the ones of Oct4 and Sox2, thus the concentrations of the single 
proteins can be neglected; (b) post-transcriptional interactions can be ignored, 
considering just the transcriptional ones; (c) Nanog is mainly regulated by the Oct4-
Sox2 heterodimer, and by itself; (d) Dkk1 is inhibited by Nanog; (e) β-catenin is 
directly inhibited by Dkk1; (f) activation and repression are Hill-like functions; (g) the 
decays rates are first order. Bistability is given by the presence of Nanog auto-positive 
feedback loop (Siciliano	  et	  al.,	  2013;	  Siciliano	  et	  al.,	  2011). 
 
Time-lapse imaging confocal specifications 
Time-lapse images were acquired on a Leica SP8 AOBS confocal laser scanning 
microscope attached to a Leica DM I6000 inverted epifluorescence microscope using 
Adaptive Focus Control to correct focus drift during time-courses and hybrid (GaAsP) 
detectors to increase sensitivity.  
 
Statistical Analysis 
Differences between groups were analyzed by Student t test. A p-value lower than 
0.05 was considered statistically significant. 
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